Oct. 2 (Bloomberg) -- Israel’s TA-25 Index declined for the first time in four days, retreating 2.2 percent to 1,054.2 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.1 billion shekels ($293 million) in shares and convertible securities, according to Tel Aviv Stock Exchange data.
The following stocks rose or fell today. Symbols are in parentheses.
Brainsway Ltd. (BRIN IT) gained the most since Aug. 31, climbing 4.7 percent to 17.75 shekels. The maker of devices to treat neurological disorders said Israel’s Health Ministry approved its Deep TMS device to treat major depression, bipolar depression and schizophrenia.
Elbit Systems Ltd. (ESLT IT) advanced to the highest level in almost a month, increasing 1.9 percent to 152.30 shekels. Israel’s largest non-government defense contractor won a contract to establish the Defense Ministry’s $280 million communications equipment project.
Gazit-Globe Ltd. (GLOB IT) fell the most since Sept. 19, sliding 2.9 percent to 37.02 shekels. The property company raised its holding in Atrium European Real Estate Ltd. to 31 percent.
Mazor Robotics Ltd. (MZOR IT) surged the most since May 2009, jumping 22 percent to 3.53 shekels. The maker of surgical robots signed agreements to sell two of its Renaissance systems to customers in the U.S. and Germany.
Ratio Oil Exploration 1992 LP (RATIL IT) soared the most since Feb. 22, increasing 8.8 percent to 0.286 shekel. The partners in Israel’s largest natural-gas discovery said drilling at the Leviathan 3 site will be finished in mid-November. Partners in the project Avner Oil Exploration-LP (AVNRL IT) climbed 2.8 percent to 1.748 shekels and Delek Drilling-LP (DEDRL IT) advanced 2.2 percent to 9.69 shekels.
Strauss Group Ltd. (STRS IT) fell the most since Aug. 7, declining 7.4 percent to 45 shekels. The food company that derived about a fifth of its 2010 revenue from dairy products said it was cutting the price of some of its milk products 12 percent.
Teva Pharmaceutical Industries Ltd. (TEVA IT) jumped the most since Dec. 9, adding 5.7 percent to 140.70 shekels, the equivalent of $37.53. The U.S.-traded shares of the world’s largest maker of generic drugs closed at $37.22 on Sept. 30.
--Editors: Shanthy Nambiar, Claudia Maedler
-0- Oct/02/2011 12:45 GMT
-0- Oct/02/2011 12:52 GMT
To contact the reporter on this story: Susan Lerner in Jerusalem at firstname.lastname@example.org
To contact the editor responsible for this story: Claudia Maedler at email@example.com -0- Oct/02/2011 12:34 GMT